TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them December 5, 1975
TCL Archive In Brief: Budget Resolution Calls For 1% Cut In NIH, Then Six Years At 3% Below Current Budget July 7, 1995
TCL Archive Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue March 29, 2013
